发明名称 INHIBITORS OF NUCLEOSIDE METABOLISM
摘要 The present invention provides compounds having formula (I) wherein A is CH or N; B is chosen from OH, NH2, NHR, H or halogen; D is chosen from OH, NH2, NHR, H, halogen or SCH3; R is an optional ly substituted alkyl, aralkyl or aryl group; and X and Y are independently selected from H, OH or halogen except that when one of X a nd Y is hydroxy or halogen, the other is hydrogen; and Z is OH or, when X is hydroxy, Z is selected from hydrogen, halogen, hydroxy, SQ or OQ, Q is an optionally substituted alkyl, aralkyl or aryl group; or a tautomer thereof; of a pharmaceutically acceptable salt thereof; or an ester thereof; or a prodrug thereof; and compounds having formula (Ia) wherein A, X, Y, Z and R are defined for compounds of formula (I) where first shown above; E is chosen from CO2H or a corresponding salt fonn, CO2R, CN, CONH2, CONHR or CONR2; and G is chos en from NH2, NHCOR, NHCONHR or NHCSNHR; or a tautomer thereof, or a pharmaceutically acceptable salt thereof, or an ester thereof, of a prodrug thereof. The present invention also provides the use of the above compounds as pharmaceuticals, pharmaceutical compositions containing the compounds and processes for preparing the compounds.
申请公布号 CA2305760(C) 申请公布日期 2008.06.03
申请号 CA19982305760 申请日期 1998.10.14
申请人 ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY;INDUSTRIAL RESEARCH LIMITED 发明人 FURNEAUX, RICHARD HUBERT;SCHRAMM, VERN L.;TYLER, PETER CHARLES
分类号 C07D487/04;C07H19/04;A01N43/04;A01N61/00;A61K31/519;A61K31/7064;A61P33/02;A61P33/06;A61P37/02;A61P37/06;A61P43/00;C07D207/34;C07D403/04;C07D487/02;C07H19/00;C07H19/06;C07H19/14;C07H21/00 主分类号 C07D487/04
代理机构 代理人
主权项
地址